The Food and Drug Administration () is planning on green lighting plans to make America's supply of vaccines last longer by slashing the dosage 80 percent and changing the way it is delivered to patients.reports that in order to quell a shortage of the Jynneos monkeypox vaccine officials are planning on delivering doses of the vaccine that are only 0.1 milliliter (ml) - a massive fall from the 0.5 ml standard dose. They believe that using an intradermal injection - which delivers the vaccine between the layers of the skin instead of underneath the skin's fat - will make sure the shot is just as effective.It comes in response to a massive shortage in monkeypox vaccines available in the U.S. Officials have so far distributed only 600,000 doses to state and local jurisdictions around the country. When jabs have become available in major population centers like New York City, appointments have been filled within minutes due to the exceedingly high demand.
Load More
Load More